Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're considering weight loss injections through a private clinic, the two licensed options in the UK are tirzepatide (Mounjaro) and semaglutide (Wegovy) — both prescription-only medicines that require a clinical assessment before a prescriber can issue a prescription. Neither can be dispensed legally without one. The right choice between clinic types, and between medicines, depends on factors worth understanding before you commit.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people search for a private clinic for weight loss injections, they usually picture a physical building. That's a reasonable starting point, but the regulatory reality is broader. A GPhC-registered online pharmacy with its own Independent Prescribers carries the same legal obligations as a bricks-and-mortar clinic, the prescription must be issued by a qualified clinician who has assessed you, the medicine must come from a licensed UK supply chain, and the pharmacy must be verifiable on the GPhC register.
What varies between providers is the shape of that clinical encounter. An in-person appointment at a private weight management clinic gives you a face-to-face conversation; a regulated online pharmacy typically uses a structured consultation form, reviewed personally by a prescriber, sometimes alongside a video call for identity and weight verification. Neither is inherently safer than the other, the legal and clinical standard required is identical. What matters is whether the provider meets it.
A common misconception is that online services skip the clinical gatekeeping entirely. Legitimate ones don't. The prescriber still reviews your full medical history, your current medications and your BMI before deciding whether to issue a prescription. If you want to check any provider's credentials, the GPhC's public register takes under a minute to search.
Our clinical team at nume reviews every consultation personally (a real prescriber, not automated software) and that applies to first consultations and every repeat order.
Both licensed injections work on gut-hormone pathways to reduce appetite and slow gastric emptying, but they're not identical. Mounjaro (tirzepatide) activates two receptors (GIP and GLP-1) making it the only dual-agonist weight-loss medicine available in the UK. Wegovy (semaglutide) targets GLP-1 alone. In the SURMOUNT-5 head-to-head trial, published in the New England Journal of Medicine in 2025, tirzepatide produced greater average weight reduction than semaglutide 2.4 mg over 72 weeks, though both medicines showed meaningful results in their own large trials.
The licensed eligibility criteria for private prescribing are straightforward in principle: adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A BMI figure alone doesn't settle it, the prescriber looks at the full clinical picture, including any contraindications.
Treatment is not recommended during pregnancy, while breastfeeding, or when trying to conceive. It is not licensed for under-18s. Anyone with a history of medullary thyroid carcinoma or certain gastrointestinal conditions will need to discuss this with a prescriber before starting. The NHS medicines page for tirzepatide sets out the side-effect profile and key precautions clearly, and is a good reference before any consultation.
If you want to understand the full range of weight loss injections available in the UK, including how the two medicines compare, that's a useful place to start before deciding which route to pursue.
Cost is rarely the cleanest signal when choosing between private providers. A low headline figure sometimes reflects a stripped-back service: no prescription fee included, delivery charged separately, no structured aftercare, and no clinical review before a repeat order is sent. A higher price may include all of those things in one transparent total, or it may not. The only way to know is to check what's included line by line.
Since Eli Lilly raised the UK list price for Mounjaro from 1 September 2025, the highest-dose pen's list price rose to around £330; typical private prices across providers now range roughly £149 to £375 per month depending on dose and supplier, as widely reported. These figures give a sense of the market; they are not a floor or a ceiling for any individual provider.
For a more detailed breakdown of what drives private treatment costs, our weight loss injections prices page covers the factors worth understanding before you commit. And if you're weighing a private clinic against NHS access, the NHS route for weight loss injections has its own eligibility rules and waiting-list realities worth reading first.
One practical note: discount codes for prescription medicines from unverified sellers are a red flag, not a saving. The MHRA has warned repeatedly about counterfeit weight-loss pens circulating online, some containing harmful substances. Any supplier offering these medicines without a clinical assessment falls outside the law. Verify the pharmacy on the GPhC register before you hand over any personal or payment information.
At nume the process is built around the same clinical standards a physical clinic operates under, delivered without the need for travel or waiting-room appointments. You complete a free consultation; a GPhC-registered Independent Prescriber reads your answers the same day and makes a clinical decision. Identity is verified by photo ID, and weight is confirmed on a live video call, not taken on trust. If the prescriber approves treatment, your prescription is issued and the medicine is dispatched the same day for orders placed before 12pm on a weekday, arriving the next working day via tracked DPD delivery in plain packaging.
Every repeat order goes through clinical re-review before it's approved. There are no subscriptions, no auto-renewals. If something changes in your health between orders, that's the moment the prescriber catches it.
If you're curious whether a physical private clinic for weight loss injections near you might suit your situation better, that page sets out what in-person routes tend to offer and how they compare. For a broader look at private weight loss injections generally, including how to judge any provider's credentials, there's more detail there too.
When you're ready to find out whether treatment is clinically appropriate for you, our weight loss clinic injections page explains exactly how the clinical process works before you start your free consultation and a prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.